$193 Million is the total value of Sio Capital Management, LLC's 54 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 82.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AXGT | Buy | AXOVANT SCIENCES LTDput | $25,034,000 | +3533.4% | 3,638,700 | +12151.5% | 12.99% | +3872.2% |
| SAGE | Buy | SAGE THERAPEUTICS INCput | $11,862,000 | +148.3% | 190,400 | +217.3% | 6.16% | +171.0% |
| QTNT | Sell | QUOTIENT LTD | $11,557,000 | -33.6% | 2,344,311 | -0.9% | 6.00% | -27.5% |
| ADMP | Buy | ADAMIS PHARMACEUTICALS CORP | $10,115,000 | +1487.9% | 1,935,961 | +1480.3% | 5.25% | +1632.0% |
| INSM | Buy | INSMED INCput | $8,327,000 | +82.0% | 266,800 | +0.1% | 4.32% | +98.8% |
| AET | Sell | AETNA INC | $8,034,000 | +1.8% | 50,523 | -2.8% | 4.17% | +11.1% |
| AXGT | New | AXOVANT SCIENCES LTD | $7,698,000 | – | 1,118,894 | +100.0% | 3.99% | – |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $6,971,000 | +42.9% | 171,694 | +51.8% | 3.62% | +56.0% |
| AGIO | AGIOS PHARMACEUTICALS INCput | $5,547,000 | +29.8% | 83,100 | 0.0% | 2.88% | +41.7% | |
| SGEN | SEATTLE GENETICS INCput | $5,441,000 | +5.2% | 100,000 | 0.0% | 2.82% | +14.8% | |
| BIIB | New | BIOGEN INC | $4,869,000 | – | 15,549 | +100.0% | 2.53% | – |
| GMED | Buy | GLOBUS MEDICAL INCcl a | $4,380,000 | +16.5% | 147,364 | +30.0% | 2.27% | +27.3% |
| MDT | Buy | MEDTRONIC PLC | $4,343,000 | +63.1% | 55,844 | +86.1% | 2.25% | +78.1% |
| KURA | New | KURA ONCOLOGY INC | $4,122,000 | – | 275,731 | +100.0% | 2.14% | – |
| GSK | New | GLAXOSMITHKLINE PLCcall | $4,060,000 | – | 100,000 | +100.0% | 2.11% | – |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $3,971,000 | +8.1% | 1,563,307 | +16.2% | 2.06% | +18.0% |
| HYH | Sell | HALYARD HEALTH INC | $3,914,000 | -1.0% | 86,914 | -13.6% | 2.03% | +8.1% |
| EGRX | New | EAGLE PHARMACEUTICALS INC | $3,807,000 | – | 63,835 | +100.0% | 1.98% | – |
| EBS | New | EMERGENT BIOSOLUTIONS INC | $3,651,000 | – | 90,268 | +100.0% | 1.89% | – |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $3,634,000 | – | 31,033 | +100.0% | 1.89% | – |
| AAAP | Sell | ADVANCED ACCELERATOR APPLICATIONS SAsponsored ads | $3,556,000 | -16.1% | 52,582 | -51.5% | 1.84% | -8.3% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $3,260,000 | -53.4% | 27,221 | -66.0% | 1.69% | -49.1% |
| ZTS | New | ZOETIS INCput | $3,188,000 | – | 50,000 | +100.0% | 1.65% | – |
| PHG | Sell | KONINKLIJKE PHILIPS NVny reg sh new | $2,795,000 | -60.1% | 67,829 | -65.3% | 1.45% | -56.4% |
| ICLR | New | ICON PLC | $2,688,000 | – | 23,604 | +100.0% | 1.40% | – |
| ITGR | New | INTEGER HOLDINGS CORP | $2,622,000 | – | 51,258 | +100.0% | 1.36% | – |
| ISRG | Sell | INTUITIVE SURGICAL INCput | $2,615,000 | -69.6% | 2,500 | -72.8% | 1.36% | -66.8% |
| ANTM | Sell | ANTHEM INC | $2,548,000 | -1.6% | 13,418 | -2.5% | 1.32% | +7.4% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $2,376,000 | – | 20,225 | +100.0% | 1.23% | – |
| LMNX | LUMINEX CORP | $2,358,000 | -3.7% | 115,979 | 0.0% | 1.22% | +5.1% | |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $2,261,000 | – | 14,874 | +100.0% | 1.17% | – |
| SNY | Sell | SANOFI SAsponsored adr | $2,245,000 | -74.2% | 45,099 | -75.2% | 1.16% | -71.8% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $2,239,000 | -42.9% | 11,430 | -46.0% | 1.16% | -37.7% |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $2,133,000 | +29.9% | 421,635 | +19.4% | 1.11% | +41.9% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $1,838,000 | +57.1% | 72,086 | +3.9% | 0.95% | +71.6% |
| VCRA | VOCERA COMMUNICATIONS INC | $1,760,000 | +18.8% | 56,106 | 0.0% | 0.91% | +29.7% | |
| EVH | New | EVOLENT HEALTH INCcl a | $1,399,000 | – | 78,600 | +100.0% | 0.73% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $1,213,000 | – | 26,958 | +100.0% | 0.63% | – |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $960,000 | -4.8% | 91,413 | 0.0% | 0.50% | +4.0% | |
| ATNM | New | ACTINIUM PHARMACEUTICALS INC | $915,000 | – | 1,590,267 | +100.0% | 0.48% | – |
| FOMX | FOAMIX PHARMACEUTICALS LTD | $773,000 | +19.7% | 139,200 | 0.0% | 0.40% | +30.6% | |
| DBVT | New | DBV TECHNOLOGIES SAput | $772,000 | – | 18,200 | +100.0% | 0.40% | – |
| XNCR | New | XENCOR INC | $759,000 | – | 33,100 | +100.0% | 0.39% | – |
| ACHC | New | ACADIA HEALTHCARE COMPANY INCput | $659,000 | – | 13,800 | +100.0% | 0.34% | – |
| PGNX | New | PROGENICS PHARMACEUTICALS INC | $652,000 | – | 88,523 | +100.0% | 0.34% | – |
| AGLE | AEGLEA BIO THERAPEUTICS INC | $639,000 | +28.1% | 129,583 | 0.0% | 0.33% | +40.1% | |
| CBAY | New | CYMABAY THERAPEUTICS INC | $605,000 | – | 75,000 | +100.0% | 0.31% | – |
| OTIC | New | OTONOMY INCput | $328,000 | – | 100,900 | +100.0% | 0.17% | – |
| OTIC | New | OTONOMY INC | $328,000 | – | 100,900 | +100.0% | 0.17% | – |
| PFNX | PFENEX INC | $259,000 | -24.7% | 85,867 | 0.0% | 0.13% | -17.8% | |
| OASMY | OASMIA PHARMACEUTICAL ABadr | $211,000 | -1.4% | 203,170 | 0.0% | 0.11% | +6.9% | |
| CCXI | Sell | CHEMOCENTRYX INC | $187,000 | -91.8% | 25,182 | -89.7% | 0.10% | -91.1% |
| STDY | Sell | STEADYMED LTD | $184,000 | -82.6% | 54,950 | -67.3% | 0.10% | -81.1% |
| SNSS | SUNESIS PHARMACEUTICALS INC | $65,000 | -28.6% | 33,710 | 0.0% | 0.03% | -20.9% | |
| PHG | Exit | KONINKLIJKE PHILIPS NVcall | $0 | – | -8,900 | -100.0% | -0.15% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -160,000 | -100.0% | -0.42% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -12,500 | -100.0% | -0.56% | – |
| ZYNE | Exit | ZYNERBA PHARMACEUTICALS INC | $0 | – | -70,300 | -100.0% | -0.57% | – |
| MED | Exit | MEDIFAST INCput | $0 | – | -38,500 | -100.0% | -0.76% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCput | $0 | – | -60,000 | -100.0% | -0.80% | – |
| PEN | Exit | PENUMBRA INCput | $0 | – | -20,000 | -100.0% | -0.83% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -313,947 | -100.0% | -0.96% | – |
| ELGX | Exit | ENDOLOGIX INC | $0 | – | -493,060 | -100.0% | -1.14% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -33,250 | -100.0% | -1.18% | – |
| NTUS | Exit | NATUS MEDICAL INC | $0 | – | -68,095 | -100.0% | -1.21% | – |
| MZOR | Exit | MAZOR ROBOTICS LTDsponsored ads | $0 | – | -73,948 | -100.0% | -1.22% | – |
| HCA | Exit | HCA HEALTHCARE INCput | $0 | – | -30,000 | -100.0% | -1.24% | – |
| SNN | Exit | SMITH & NEPHEW PLCspdn adr new | $0 | – | -77,244 | -100.0% | -1.28% | – |
| LLY | Exit | ELI LILLY AND CO | $0 | – | -33,473 | -100.0% | -1.31% | – |
| LLY | Exit | ELI LILLY AND COput | $0 | – | -40,000 | -100.0% | -1.56% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS INCput | $0 | – | -7,000 | -100.0% | -1.63% | – |
| PKI | Exit | PERKINELMER INC | $0 | – | -53,899 | -100.0% | -1.74% | – |
| TRHC | Exit | TABULA RASA HEALTHCARE INC | $0 | – | -312,630 | -100.0% | -2.24% | – |
| ABBV | Exit | ABBVIE INCput | $0 | – | -70,000 | -100.0% | -2.41% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -60,420 | -100.0% | -2.50% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -35,965 | -100.0% | -2.98% | – |
| LPNT | Exit | LIFEPOINT HEALTH INCput | $0 | – | -100,000 | -100.0% | -3.19% | – |
| AGN | Exit | ALLERGAN PLCput | $0 | – | -30,000 | -100.0% | -3.47% | – |
| ACOR | Exit | ACORDA THERAPEUTICS INCput | $0 | – | -380,000 | -100.0% | -3.56% | – |
| JNJ | Exit | JOHNSON & JOHNSONput | $0 | – | -70,000 | -100.0% | -4.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.